Lu Hongbo
Insider CIK 1767584 · AVDR Director · TPTX Director · TERN Director · ZBIO Director · ARWR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2026-06-15 | 2026-06-17 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-05-12 | 2026-05-14 | 2,970 | $76.88 | $228.3K | 52,012 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-03-31 | 2026-04-02 | 3,768 | $18.63 | $70.2K | 426,736 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-03-31 | 2026-03-31 | 75,000 | $20.00 | $1.50M | 422,968 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-02-11 | 2026-02-13 | 25,985 | $22.50 | $584.7K | 347,968 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 54,982 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2025-10-07 | 2025-10-09 | 263,160 | $19.00 | $5.00M | 321,983 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 18,500 | — | $0 | 18,500 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-02-01 | 2025-02-03 | 10,657 | — | $0 | 10,657 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 47,163 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2024-09-13 | 2025-10-09 | 58,823 | $17.00 | $1000.0K | 58,823 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2024-09-13 | 2024-09-17 | 58,823 | $17.00 | $1000.0K | 58,823 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 37,000 | — | $0 | 37,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2024-09-12 | 2024-09-17 | 190,476 | $10.50 | $2.00M | 190,476 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2024-09-12 | 2024-09-17 | 285,714 | $10.50 | $3.00M | 476,190 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-07-01 | 2024-07-02 | 4,676 | — | $0 | 4,676 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-06-10 | 2024-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | P Buy | 2024-03-20 | 2024-03-20 | 1,000 | $27.50 | $27.5K | 33,680 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | P Buy | 2024-03-19 | 2024-03-20 | 1,000 | $28.00 | $28.0K | 32,680 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | P Buy | 2024-03-18 | 2024-03-20 | 1,000 | $27.49 | $27.5K | 31,680 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-12-23 | 2022-12-23 | 758,620 | $7.25 | $5.50M | 4,340,212 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-09-07 | 2022-09-08 | 600,000 | $3.60 | $2.16M | 3,581,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-16 | 1,500,000 | $2.42 | $3.63M | 1,500,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-16 | 1,500,000 | $2.42 | $3.63M | 2,981,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-15 | 2022-08-16 | 1,218 | $2.99 | $3.6K | 1,481,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-12 | 2022-08-16 | 1,123,021 | $2.98 | $3.35M | 1,480,374 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2022-06-16 | 2022-06-21 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2021-02-24 | 2021-02-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AVDR AVEDRO INC | D To issuer deriv | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,314 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion deriv | 2019-04-22 | 2019-04-24 | 4,314,809 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2019-04-22 | 2019-04-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion deriv | 2019-04-22 | 2019-04-24 | 2,105,259 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion | 2019-04-22 | 2019-04-24 | 546,820 | — | $0 | 1,667,550 | SEC↗ |
| TPTX Turning Point Therapeutics | P Buy | 2019-04-22 | 2019-04-24 | 60,000 | $18.00 | $1.08M | 1,727,550 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion | 2019-04-22 | 2019-04-24 | 1,120,730 | — | $0 | 1,120,730 | SEC↗ |
| AVDR AVEDRO INC | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |